| Full text | |
| Author(s): |
de Oliveira, Kelly Cristina
[1]
;
Bianco, Bianca Borsatto
[1]
;
Verreschi, Ieda T. N.
[1]
;
Guedes, Alexts Dourado
[1]
;
Galera, Bianca Borsato
[2]
;
Galera, Marcial Francis
[2]
;
Barbosa, Calo P.
[3]
;
Nunes Lipay, Monica Vannucci
[4, 1]
Total Authors: 8
|
| Affiliation: | [1] Univ Fed Sao Paulo, Div Endocrinol, Dept Med, Sao Paulo - Brazil
[2] Univ Cuiaba UNIC, Gen Hosp, Med Genet & Mol Biol Unit, Cuiaba, MT - Brazil
[3] ABC, Coll Med, Div Genet, Sao Paulo - Brazil
[4] Univ Fed Sao Paulo, Dept Morphol & Genet, Div Genet, Sao Paulo - Brazil
Total Affiliations: 4
|
| Document type: | Journal article |
| Source: | Arquivos Brasileiros de Endocrinologia e Metabologia; v. 52, n. 8, p. 1374-1381, NOV 2008. |
| Web of Science Citations: | 18 |
| Abstract | |
BACKGROUND: Dysfunctions in the folate metabolism can result in DNA hypomethylation and abnormal chromosome segregation. Two common polymorphisms of this enzyme (C677T and A1298C) reduce its activity, but when associated with aneuploidy studies the results are conflicting. The objective of the present study is to analyze the MTHFR gene polymorphisms in women with Turner Syndrome and in a control group, correlating the findings to the chromosomal aneuploidy. METHODS: The study comprised 140 patients with Turner Syndrome, of which 36 with chromosome mosaicism and 104 non-mosaics, and a control group of 209 fertile and healthy women without a history of any offspring with aneuploidy. Polymorphisms C677T and A1298C were studied by RFLP-PCR and the results were statistically analyzed. RESULTS: The frequency of genotypes MTHFR 677CC, 677CT and 677TT in the patients with Turner Syndrome and chromosome mosaicism was, respectively, 58.3%, 38.9% and 2.8%. Among the patients with non-mosaic Turner Syndrome, 47.1% presented genotype 677CC, 45.2% genotype 677CT, and 7.7% genotype 677TT. Among the 209 individuals of the control group, genotypes 677CC, 677CT and 677TT were found at the following frequencies: 48.3%, 42.1% and 9.6%, respectively. As for polymorphism A1298C, the patients with Turner Syndrome and chromosome mosaicism presented genotypes 1298AA, 1298AC and 1298CC at the following frequencies: 58.3%, 27.8% and 13.9%, respectively. Among the non-mosaic Turner Syndrome patients, genotype 1298AA was found in 36.5%, genotype 1298AC in 39.4%, and genotype 1298CC in 22.1%. In the control group, genotypes 1298AA, 1298AC and 1298CC were present at the following frequencies: 52.6%, 40.7% and 6.7%, respectively. CONCLUSION: No correlation was observed between the MTHFR gene polymorphism 677 and chromosomal aneuploidy in the Turner Syndrome patients. However, the MTHFR gene polymorphism at position 1298, mainly genotype 1298CC that reduces the enzyme efficiency, was more frequent in the group of Turner Syndrome patients, suggesting its involvement in mechanisms related to chromosomal imbalances. (AU) | |
| FAPESP's process: | 07/03295-0 - Methylenetetrahydrofolate Reductase (MTHFR) polymorphisms as a risk factor for Turner Syndrome |
| Grantee: | Monica Vannucci Nunes Lipay |
| Support Opportunities: | Regular Research Grants |